The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
A committee of two joint drugs controllers has been constituted at CDSCO (HQ) to monitor the process of inspection, reporting and subsequent action so as to ensure compliance to the Drugs and Cosmetics Act, 1940, according to a statement from the ministry of health and family welfare.
In the letter to World Health Organization's director of regulation and prequalification Rogerio Gaspar, Drugs Controller General VG Somani said that the technical committee found that "the products have been found not to have been contaminated with DEG or EG as per the test reports. These r
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months for the second time, according to an order issued by the Union Health Ministry.
He was interacting with a delegation led by Rahul Gupta, Director of the White House Office of National Drug Control Policy at his Home Office Krishna. Rahul Gupta explained in detail the measures President Joe Biden's Office took to increase cooperation between India and the USA in Drug Pol
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer, by the Serum Institute of India will start in the first quarter of 2023 which got delayed due to C
New Delhi [India], October 15 (ANI): Drugs Controller General of India (DCGI) on Saturday replied to World Health Organisation (WHO) and said as per the recently formed technical committee, the clinical features and the treatment received by the children as shared by WHO so far are inadeq
New Delhi [India], September 29 (ANI): The Drugs controller general of India (DCGI) allowed the export of approximately 2 lakh vaccine doses of Malaria which is produced in India, said sources on Thursday.
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.